I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 16 studies | 21% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 13 studies | 24% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 8 studies | 23% ± 4% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 6 studies | 19% ± 1% | |
| mature NK T cell | 5 studies | 21% ± 3% | |
| non-classical monocyte | 4 studies | 27% ± 9% | |
| CD8-positive, alpha-beta T cell | 3 studies | 26% ± 6% | |
| innate lymphoid cell | 3 studies | 28% ± 8% | |
| gamma-delta T cell | 3 studies | 16% ± 1% |
